Menu
Back to User profile » Dr Andrea Antinori
Papers published by Dr Andrea Antinori:
Cardiovascular adverse events during treatment with darunavir-based regimens in an Italian observational study
Antinori A, Rusconi S, Gianotti N, Bini T, Mancusi D, Termini R
Drug Design, Development and Therapy 2019, 13:1667-1685
Published Date: 14 May 2019
Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients
Restelli U, Rizzardini G, Antinori A, Lazzarin A, Bonfanti M, Bonfanti P, Croce D
Therapeutics and Clinical Risk Management 2017, 13:787-797
Published Date: 29 June 2017
Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study
Antinori A, Meraviglia P, d’Arminio Monforte A, Castagna A, Mussini C, Bini T, Gianotti N, Rusconi S, Colella E, Airoldi G, Mancusi D, Termini R
Drug Design, Development and Therapy 2016, 10:1589-1603
Published Date: 6 May 2016
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D
ClinicoEconomics and Outcomes Research 2014, 6:409-414
Published Date: 23 September 2014
Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines
Colombo GL, Matteo SD, Antinori A, Medaglia M, Murachelli S, Rizzardini G
ClinicoEconomics and Outcomes Research 2013, 5:489-496
Published Date: 3 October 2013